DE2744174A1 - Diagnostische zubereitungen aus rotaviren - Google Patents
Diagnostische zubereitungen aus rotavirenInfo
- Publication number
- DE2744174A1 DE2744174A1 DE19772744174 DE2744174A DE2744174A1 DE 2744174 A1 DE2744174 A1 DE 2744174A1 DE 19772744174 DE19772744174 DE 19772744174 DE 2744174 A DE2744174 A DE 2744174A DE 2744174 A1 DE2744174 A1 DE 2744174A1
- Authority
- DE
- Germany
- Prior art keywords
- subunits
- rotavirus
- preparation
- suspension
- antiserum
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 241000702670 Rotavirus Species 0.000 title claims description 36
- 238000002360 preparation method Methods 0.000 title claims description 21
- 239000000725 suspension Substances 0.000 claims description 14
- 239000002775 capsule Substances 0.000 claims description 13
- 241000700605 Viruses Species 0.000 claims description 12
- 238000000034 method Methods 0.000 claims description 12
- 241000124008 Mammalia Species 0.000 claims description 9
- 210000003608 fece Anatomy 0.000 claims description 8
- 238000005119 centrifugation Methods 0.000 claims description 5
- 239000012634 fragment Substances 0.000 claims description 5
- 239000013049 sediment Substances 0.000 claims description 4
- 102000004142 Trypsin Human genes 0.000 claims description 3
- 108090000631 Trypsin Proteins 0.000 claims description 3
- 239000000872 buffer Substances 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 108090000526 Papain Proteins 0.000 claims description 2
- 239000004365 Protease Substances 0.000 claims description 2
- 238000001914 filtration Methods 0.000 claims description 2
- 239000000203 mixture Substances 0.000 claims description 2
- 229940055729 papain Drugs 0.000 claims description 2
- 235000019834 papain Nutrition 0.000 claims description 2
- 108091005804 Peptidases Proteins 0.000 claims 1
- 102000035195 Peptidases Human genes 0.000 claims 1
- 208000007536 Thrombosis Diseases 0.000 claims 1
- 210000002966 serum Anatomy 0.000 description 17
- 239000012141 concentrate Substances 0.000 description 15
- 238000012360 testing method Methods 0.000 description 11
- 208000005577 Gastroenteritis Diseases 0.000 description 9
- 239000000427 antigen Substances 0.000 description 8
- 102000036639 antigens Human genes 0.000 description 8
- 108091007433 antigens Proteins 0.000 description 8
- 238000001493 electron microscopy Methods 0.000 description 8
- 230000000295 complement effect Effects 0.000 description 6
- 238000003745 diagnosis Methods 0.000 description 5
- 244000309466 calf Species 0.000 description 4
- 238000010790 dilution Methods 0.000 description 4
- 239000012895 dilution Substances 0.000 description 4
- 210000003743 erythrocyte Anatomy 0.000 description 4
- 230000000951 immunodiffusion Effects 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- 241000700198 Cavia Species 0.000 description 3
- 206010067470 Rotavirus infection Diseases 0.000 description 3
- 230000035931 haemagglutination Effects 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000001556 precipitation Methods 0.000 description 3
- FTOAOBMCPZCFFF-UHFFFAOYSA-N 5,5-diethylbarbituric acid Chemical compound CCC1(CC)C(=O)NC(=O)NC1=O FTOAOBMCPZCFFF-UHFFFAOYSA-N 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 108010006464 Hemolysin Proteins Proteins 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 241000702244 Orthoreovirus Species 0.000 description 2
- 241001494479 Pecora Species 0.000 description 2
- 241000282887 Suidae Species 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 2
- 239000003228 hemolysin Substances 0.000 description 2
- 230000001900 immune effect Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 230000001404 mediated effect Effects 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- 239000002953 phosphate buffered saline Substances 0.000 description 2
- 230000000405 serological effect Effects 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 239000012588 trypsin Substances 0.000 description 2
- 230000003612 virological effect Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 229920000936 Agarose Polymers 0.000 description 1
- 208000031504 Asymptomatic Infections Diseases 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 229960002319 barbital Drugs 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000007975 buffered saline Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 238000000432 density-gradient centrifugation Methods 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 230000002550 fecal effect Effects 0.000 description 1
- 238000012817 gel-diffusion technique Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 244000144980 herd Species 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 210000002425 internal capsule Anatomy 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 238000003127 radioimmunoassay Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/12011—Reoviridae
- C12N2720/12311—Rotavirus, e.g. rotavirus A
- C12N2720/12322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Virology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB40608/76A GB1539221A (en) | 1976-09-30 | 1976-09-30 | Viral preparations |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE2744174A1 true DE2744174A1 (de) | 1978-04-27 |
Family
ID=10415735
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19772744174 Withdrawn DE2744174A1 (de) | 1976-09-30 | 1977-09-30 | Diagnostische zubereitungen aus rotaviren |
Country Status (9)
| Country | Link |
|---|---|
| JP (1) | JPS5344625A (enrdf_load_stackoverflow) |
| BE (1) | BE859289A (enrdf_load_stackoverflow) |
| CH (1) | CH633825A5 (enrdf_load_stackoverflow) |
| DE (1) | DE2744174A1 (enrdf_load_stackoverflow) |
| DK (1) | DK433277A (enrdf_load_stackoverflow) |
| FR (1) | FR2366360A1 (enrdf_load_stackoverflow) |
| GB (1) | GB1539221A (enrdf_load_stackoverflow) |
| NL (1) | NL7710729A (enrdf_load_stackoverflow) |
| SE (1) | SE445392B (enrdf_load_stackoverflow) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE445466B (sv) * | 1977-12-01 | 1986-06-23 | Wellcome Found | Sett att foroka rotavirus in vitro |
| JPS6237259A (ja) * | 1985-08-12 | 1987-02-18 | Honda Motor Co Ltd | 車両用アンチロツク制御装置の作動確認装置 |
-
1976
- 1976-09-30 GB GB40608/76A patent/GB1539221A/en not_active Expired
-
1977
- 1977-09-30 SE SE7710955A patent/SE445392B/xx not_active IP Right Cessation
- 1977-09-30 CH CH1199277A patent/CH633825A5/de not_active IP Right Cessation
- 1977-09-30 NL NL7710729A patent/NL7710729A/xx not_active Application Discontinuation
- 1977-09-30 BE BE181387A patent/BE859289A/xx not_active IP Right Cessation
- 1977-09-30 JP JP11777777A patent/JPS5344625A/ja active Granted
- 1977-09-30 FR FR7729433A patent/FR2366360A1/fr active Granted
- 1977-09-30 DK DK433277A patent/DK433277A/da not_active Application Discontinuation
- 1977-09-30 DE DE19772744174 patent/DE2744174A1/de not_active Withdrawn
Non-Patent Citations (6)
| Title |
|---|
| Archiv für die gesamte Virusforschung 37, 114-130, 1972 * |
| Br. J. Vener, Dis. 1973, 49, 3 * |
| J. Clin. Path. 1974, 27, 603-614 * |
| Lancet, 1975, 1, 1056-1061 * |
| Public Health Laboratory Services Bulletin, 1962, 21, 96 * |
| Science, 185, 1049-1053, 1974 * |
Also Published As
| Publication number | Publication date |
|---|---|
| SE7710955L (sv) | 1978-03-31 |
| DK433277A (da) | 1978-03-31 |
| FR2366360B1 (enrdf_load_stackoverflow) | 1983-12-16 |
| JPS6129463B2 (enrdf_load_stackoverflow) | 1986-07-07 |
| NL7710729A (nl) | 1978-04-03 |
| GB1539221A (en) | 1979-01-31 |
| BE859289A (fr) | 1978-03-30 |
| CH633825A5 (en) | 1982-12-31 |
| FR2366360A1 (fr) | 1978-04-28 |
| JPS5344625A (en) | 1978-04-21 |
| SE445392B (sv) | 1986-06-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Penfoldi et al. | Autoantibodies to retinal astrocytes associated with age-related macular degeneration | |
| EP0023989B1 (de) | Enzym-Immuntest zum Nachweis von Erreger-spezifischen Antikörpern und Testsatz für die Durchführung dieses Tests | |
| DE4139840A1 (de) | Antigen-zubereitung zum nachweis von h. pylori | |
| DE2639623A1 (de) | Mittel und verfahren zur neoplasmadiagnose | |
| EP0124896B1 (de) | Verfahren zur Gewinnung von Viren bzw. Virusantigenen und deren Anwendung in Diagnose und Therapie (Impfstoff) | |
| Lennette et al. | Studies on epidemic influenza virus: The nature and properties of the complement-fixing antigen | |
| DE2403994A1 (de) | Herstellung von antisera | |
| Rosenthal et al. | Reversible agglutination of trypsin treated erythrocytes by normal human sera. | |
| DE3105555A1 (de) | Reagens zum nachweis des rheumatoidfaktors, verfahren zu seiner herstellung und seine verwendung | |
| EP0037963A2 (de) | Neues Protein PP9, Verfahren zu seiner Gewinnung sowie seine Verwendung | |
| CH645727A5 (de) | Praeparat zur bestimmung von menschlichem beta-2-mikroglobulin, verfahren zu seiner herstellung und seine verwendung. | |
| DE2744174A1 (de) | Diagnostische zubereitungen aus rotaviren | |
| US4190645A (en) | Rotavirus inner capsid subunit preparations | |
| DE2742835A1 (de) | Antigenfraktionen von schistosoma mansoni-eiern, geeignet fuer die untersuchung von schistosomiasis | |
| EP0011716B1 (de) | Reagenz zum Nachweis von infektiöser Mononucleose und Verfahren zu seiner Herstellung | |
| DE3410694C2 (enrdf_load_stackoverflow) | ||
| EP0363449B1 (de) | Verfahren zur untersuchung von antikörpern spezifisch für rheumakrankheiten, insbesondere chronische polyarthritis sowie reagens hierfür | |
| Jordan et al. | A community study of Schistosoma mansoni egg excretion assessed by the Bell and a modified Kato technique | |
| DE3887124T2 (de) | VERFAHREN ZUR BESTIMMUNG VON IgM-ANTIKÖRPERN. | |
| DE69813555T2 (de) | Gegen die fläche von cryptosporidium-oozysten gerichteten igg1-klasse antikörper | |
| DE3322643C2 (de) | Verfahren zur Herstellung eines Latextestreagenz zum Nachweis und zur Differenzierung von Humanhämoglobin, Humanhämoglobinbestandteilen oder Humanhämoglobinvarianten | |
| DE2555188A1 (de) | Immunologische analyse | |
| Merry et al. | A rapid purification method for peanut anti-T lectin | |
| DE3135124A1 (de) | "verfahren zum nachweis maligner neoplasien der weiblichen brustdruese des menschen mit hilfe spezifischer antikoerper gegen die vermutlich verantwortlichen viruspartikel sowie zum nachweis dieser viruspartikel oder ihrer antigene und reagentien zur durchfuehrung des verfahrens" | |
| DE2205897A1 (de) | Verfahren zur Herstellung von antigenen Extrakten tierischer Thymocythen und tierartspezifischen antithymocytären Seren und Gamma-Globulinen sowie entsprechende Extrakte, Seren und Gamma-Globuline und diese enthaltende Pharmazeutika |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8110 | Request for examination paragraph 44 | ||
| 8128 | New person/name/address of the agent |
Representative=s name: BERG, W., DIPL.-CHEM. DR.RER.NAT. SCHWABE, H., DIP |
|
| 8130 | Withdrawal |